EPS Bio Technology Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for EPS Bio Technology.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Medical Equipment earnings growth | 22.3% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Should You Or Shouldn't You: A Dividend Analysis on EPS Bio Technology Corp. (GTSM:4183)
Apr 16
Will EPS Bio Technology (GTSM:4183) Multiply In Value Going Forward?
Mar 20Here's Why We Think EPS Bio Technology's (GTSM:4183) Statutory Earnings Might Be Conservative
Feb 22Do Fundamentals Have Any Role To Play In Driving EPS Bio Technology Corp.'s (GTSM:4183) Stock Up Recently?
Feb 01
Should EPS Bio Technology Corp. (GTSM:4183) Be Part Of Your Dividend Portfolio?
Jan 04Is EPS Bio Technology (GTSM:4183) Likely To Turn Things Around?
Dec 14We Think EPS Bio Technology's (GTSM:4183) Statutory Profit Might Understate Its Earnings Potential
Nov 23In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as EPS Bio Technology has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 9/30/2024 | 485 | 30 | -4 | 10 | N/A |
| 6/30/2024 | 498 | 34 | 9 | 28 | N/A |
| 3/31/2024 | 477 | 30 | 28 | 45 | N/A |
| 12/31/2023 | 470 | 21 | 46 | 55 | N/A |
| 9/30/2023 | 424 | 20 | 47 | 63 | N/A |
| 6/30/2023 | 454 | 24 | 25 | 34 | N/A |
| 3/31/2023 | 442 | 25 | -27 | -14 | N/A |
| 12/31/2022 | 463 | 25 | -10 | 5 | N/A |
| 9/30/2022 | 506 | 36 | 4 | 14 | N/A |
| 6/30/2022 | 485 | 25 | 21 | 35 | N/A |
| 3/31/2022 | 504 | 26 | 41 | 53 | N/A |
| 12/31/2021 | 480 | 19 | 20 | 32 | N/A |
| 9/30/2021 | 451 | 7 | -21 | -10 | N/A |
| 6/30/2021 | 435 | 15 | -2 | 8 | N/A |
| 3/31/2021 | 459 | 22 | 38 | 47 | N/A |
| 12/31/2020 | 478 | 32 | 73 | 80 | N/A |
| 9/30/2020 | 497 | 34 | 114 | 124 | N/A |
| 6/30/2020 | 489 | 28 | 77 | 91 | N/A |
| 3/31/2020 | 466 | 19 | 40 | 55 | N/A |
| 12/31/2019 | 459 | 18 | 5 | 22 | N/A |
| 9/30/2019 | 437 | 33 | 1 | 20 | N/A |
| 6/30/2019 | 443 | 31 | -2 | 13 | N/A |
| 3/31/2019 | 445 | 41 | 23 | 37 | N/A |
| 12/31/2018 | 414 | 16 | -3 | 13 | N/A |
| 9/30/2018 | 431 | 13 | -3 | 9 | N/A |
| 6/30/2018 | 404 | 9 | N/A | 12 | N/A |
| 3/31/2018 | 390 | -12 | N/A | 15 | N/A |
| 12/31/2017 | 420 | 3 | N/A | 42 | N/A |
| 9/30/2017 | 434 | 2 | N/A | 15 | N/A |
| 6/30/2017 | 453 | 4 | N/A | 34 | N/A |
| 3/31/2017 | 466 | 27 | N/A | 58 | N/A |
| 12/31/2016 | 467 | 29 | N/A | 41 | N/A |
| 9/30/2016 | 420 | 18 | N/A | 33 | N/A |
| 6/30/2016 | 426 | 33 | N/A | 41 | N/A |
| 3/31/2016 | 416 | 24 | N/A | 33 | N/A |
| 12/31/2015 | 425 | 37 | N/A | 57 | N/A |
| 9/30/2015 | 426 | 29 | N/A | 83 | N/A |
| 6/30/2015 | 419 | 7 | N/A | 94 | N/A |
| 3/31/2015 | 372 | -13 | N/A | 44 | N/A |
| 12/31/2014 | 324 | -33 | N/A | -6 | N/A |
| 9/30/2014 | 339 | -26 | N/A | -25 | N/A |
| 6/30/2014 | 353 | -18 | N/A | -45 | N/A |
| 3/31/2014 | 369 | -4 | N/A | 0 | N/A |
| 12/31/2013 | 384 | 9 | N/A | 46 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 4183's forecast earnings growth is above the savings rate (1.1%).
Earnings vs Market: Insufficient data to determine if 4183's earnings are forecast to grow faster than the TW market
High Growth Earnings: Insufficient data to determine if 4183's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if 4183's revenue is forecast to grow faster than the TW market.
High Growth Revenue: Insufficient data to determine if 4183's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 4183's Return on Equity is forecast to be high in 3 years time